Brugada J, et al. Present status of Brugada syndrome. Journal of the American College of Cardiology. 2018; doi:10.1016/j.jacc.2018.06.037.
Medical review (expert opinion). Mayo Clinic. Feb. 18, 2020.
Wylie JV, et al. Brugada syndrome: Prognosis, management, and approach to screening. https://www.uptodate.com/contents/search. Accessed Feb. 3, 2022.
Kusumoto FM, et al. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Heart Rhythm. 2018; doi:10.1016/j.hrthm.2017.10.037.
Li KHC, et al. Brugada syndrome: A comprehensive review of pathophysiological mechanisms and risk stratification strategies. International Journal of Cardiology. Heart & Vasculature. 2020; doi:10.1016/j.ijcha.2020.100468.
Tisdale JE, et al. Drug-induced arrhythmias: A scientific statement from the American Heart Association. Circulation. 2020; doi:10.1161/CIR.0000000000000905.
Al-Khatib SM, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018; doi:10.1161/CIR.0000000000000549.